Assertio Therapeutics revenue

Assertio Therapeutics revenue decreased from $380.7 million in 2017 to $311.8 million in 2018, a 18.1% decrease.

Annual Revenue ($)

Assertio Therapeutics revenue was $311.77 m in FY, 2018

Quarterly Revenue ($)

FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018
Revenue$134.21 m$390.36 m$342.74 m$455.90 m$380.72 m$311.77 m
Growth190.87%(12.2%)33.02%
Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019
Revenue$37.46 m$76.54 m$67.73 m$51.49 m$32.20 m$94.50 m$104.86 m$104.78 m$116.68 m$110.52 m$90.45 m$100.46 m$95.41 m$128.40 m$63.27 m$77.49 m$57.93 m$57.20 m

Annual Growth Rate (%)